About Macrodeep
New report 2026 AI SDR market benchmark: six platforms, eight workflow stages See the results →

Il rapporto

Notizie verificate su finanziamenti, sedi centrali e leadership delle aziende più innovative al mondo

359 report e oltre

Aggiornato quotidianamente con le ultime intelligence di mercato
Fundraising
Basecamp Research

Basecamp Research Raises $140M Series C for AI-Designed Medicines

Basecamp Research raised a $140 million Series C led by S32 to train new EDEN models and advance AI-designed therapeutics toward clinical development.

SalesTools Research
Sep 23, 2026
2 min read•$140M
Fundraising
Ande

Ande Emerges From Stealth With $52M in Seed and Series A Funding

Ande launched with more than $52 million from Lightspeed, Redpoint, Duration, Sierra Ventures, and Bain Capital Ventures for enterprise entertainment spend.

SalesTools Research
Sep 22, 2026
2 min read•$52M+
Fundraising
MIND

MIND Raises $72M Series B for AI-Native Data Loss Prevention

MIND raised a $72 million Series B led by Crosspoint Capital Partners, bringing total funding to $112 million for its AI-native DLP platform.

SalesTools Research
Sep 17, 2026
2 min read•$72M
Headquarters
Riverlane

Riverlane Establishes US Headquarters in Maryland

Quantum-error-correction company Riverlane is establishing its US headquarters with office and laboratory space in College Park, Maryland.

SalesTools Research
Sep 17, 2026
2 min read
Fundraising
Profound

Profound Raises $180M Series D at a $1.8B Valuation

Profound raised a $180 million Series D co-led by Sequoia and Kleiner Perkins to expand its AI platform for enterprise marketing teams.

SalesTools Research
Sep 15, 2026
2 min read•$180M
Fundraising
Levanta

Levanta Raises $22M Series B for Creator Commerce Infrastructure

Levanta raised a $22 million Series B led by Volition Capital, bringing total funding above $43 million as it expands across retail marketplaces.

SalesTools Research
Aug 27, 2026
2 min read•$22M
Fundraising
Leal Therapeutics

Leal Therapeutics Raises $30M Series A Extension for Neuro-Metabolic Drugs

Leal Therapeutics raised a $30 million second close of its Series A, including new investor Eli Lilly, to advance LTX-001 in schizophrenia and LTX-002 in ALS.

SalesTools Research
Aug 17, 2026
2 min read•$30M
Fundraising
Beyang

Beyang Raises Nearly $30M Series A for AI-Driven Drug Discovery

Beyang Therapeutics raised nearly $30 million in an oversubscribed Series A co-led by Legend Capital and Shanghai Healthcare Capital to advance its AI-driven drug discovery platform and pipeline.

SalesTools Research
Aug 12, 2026
2 min read•$30M
Fundraising
Infinimmune

Infinimmune Raises $75M Series A for Human-Derived Antibody Drugs

Infinimmune raised a $75 million Series A co-led by Regeneron Ventures and Playground Global to advance human-derived antibody programs in atopic dermatitis and inflammatory disease.

SalesTools Research
Aug 11, 2026
2 min read•$75M
Pagina 1

Visualizzazione di 9 report • Pagina 1 • Categoria: all

Rimani avanti rispetto al mercato

Ricevi insight settimanali nella tua casella di posta. Niente spam, solo intelligenza.